Last Updated on November 14, 2024 by The Health Master
Pharma marketers
A recent demand from the newly formed Association of Indian Pharmaceutical Progressive Entrepreneurs (AIPPE) in Tamil Nadu for a separate license for pharma marketers has been met with a firm “no” from the Tamil Nadu State Drug Controller, MN Sridhar.
Sridhar clarified that the Drugs and Cosmetics Act doesn’t currently provide for separate licenses for marketing companies.
Pharma marketers are currently operating under wholesale licenses issued in Form 20B and 21B.
These licenses, while sufficient for their operations, don’t provide the specific recognition they seek.
The AIPPE’s Plea
The AIPPE, representing small-scale pharma manufacturers and pharma marketers, argues that they should have a distinct identity and license.
They point out that they market their own brands, unlike distributors who handle a wider range of products.
The association has written to both the central and state governments, requesting an amendment to the Drugs and Cosmetics Act to accommodate their demand.
Drug Controller’s Stance
While the drug controller understands the association’s concerns, he maintains that the current licensing system is adequate.
He plans to hold a meeting with wholesalers to clarify the purpose of each license type.
A New Era for Pharma Marketers in Tamil Nadu
The formation of AIPPE marks a new chapter for pharma marketers in Tamil Nadu.
The association aims to address various challenges faced by its members, including education, policy updates, and business development.
By uniting marketers across the state, AIPPE hopes to strengthen their collective voice and influence policy decisions.
Jayachandran, the association’s president, has plans to expand AIPPE’s reach to other states and establish a pan-India presence.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Key Notes on Revised Schedule M: Must read
Important short notes for Industry and Regulators
CDSCO Guidelines on Drug Recall
Quality Assurance Vs Quality Control in the Pharma Industry
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Marketers responsibility as per latest D&C Rules
FAQs – on Notification: Marketer of drugs
Ensuring Ethical Pharmaceutical Marketing Practices: A Comprehensive Analysis
Govt issues instructions on marketing codes of pharma companies
UCPMP: New Uniform Code for Pharmaceutical Marketing Practices: An Overview
Pharma Companies Under Scrutiny: New Rules for Marketing Practices
Pharma Printers must come under the ambit of Drugs Act
Important short notes for Industry
Deadly reactor explosion at Pharma Plant in Andhra Pradesh
Drug recall: Dr Reddy’s recalls Cinacalcet Tablets due to impurity Concerns
Indian Pharma Industry to face New GMP Regulations Compliance
Clotrimazole Cream Price Dispute: Govt upholds NPPA’s Ceiling Price
Telangana DCA takes action on 15 Medical Stores for Violations
Govt to amend MDR to include QMS requirements for Class A Medical Devices
NPPA orders Price Cut on these Cancer Drugs
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
